- Home
- NMHI vs ABVC Comparison
NMHI vs ABVC Comparison
Compare NMHI & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMHI
- ABVC
- Stock Information
- Founded
- NMHI N/A
- ABVC 2015
- Country
- NMHI United States
- ABVC United States
- Employees
- NMHI N/A
- ABVC N/A
- Industry
- NMHI
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- NMHI
- ABVC Health Care
- Exchange
- NMHI NYSE
- ABVC Nasdaq
- Market Cap
- NMHI 5.5M
- ABVC 6.5M
- IPO Year
- NMHI N/A
- ABVC N/A
- Fundamental
- Price
- NMHI $2.33
- ABVC $0.50
- Analyst Decision
- NMHI
- ABVC
- Analyst Count
- NMHI 0
- ABVC 0
- Target Price
- NMHI N/A
- ABVC N/A
- AVG Volume (30 Days)
- NMHI 1.9M
- ABVC 361.8K
- Earning Date
- NMHI 11-14-2024
- ABVC 11-14-2024
- Dividend Yield
- NMHI N/A
- ABVC N/A
- EPS Growth
- NMHI N/A
- ABVC N/A
- EPS
- NMHI N/A
- ABVC N/A
- Revenue
- NMHI $9,994,275.00
- ABVC $509,788.00
- Revenue This Year
- NMHI N/A
- ABVC N/A
- Revenue Next Year
- NMHI N/A
- ABVC N/A
- P/E Ratio
- NMHI N/A
- ABVC N/A
- Revenue Growth
- NMHI N/A
- ABVC N/A
- 52 Week Low
- NMHI $1.79
- ABVC $0.41
- 52 Week High
- NMHI $342.00
- ABVC $2.45
- Technical
- Relative Strength Index (RSI)
- NMHI 45.84
- ABVC 36.66
- Support Level
- NMHI $1.92
- ABVC $0.47
- Resistance Level
- NMHI $2.95
- ABVC $0.52
- Average True Range (ATR)
- NMHI 0.37
- ABVC 0.04
- MACD
- NMHI 0.05
- ABVC -0.00
- Stochastic Oscillator
- NMHI 45.38
- ABVC 25.56
About NMHI NATURES MIRACLE HLDG INC
Nature's Miracle Holding Inc is a growing agriculture technology company providing Controlled Environment Agriculture (CEA) hardware products to growers in the CEA industry setting in North America. It provides hardware to design, build, and operate various indoor growing settings, including greenhouse and indoor growing spaces. Its products include Horticultural Lighting, Irrigation System, Power Distribution Systems, Climate Control Systems, Disinfection Systems, and Materials And Equipment.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.